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ABSTRACT: 
Snake venom been studied for its lethality and various benefits for mankind. The latter been studied a plenty of recent 
but none related to coagulation of milk to curd.  The coagulation time of milk by samples were done using visible 
parameters i.e. change in viscosity, colour changes, white spot formation (separation between curd and whey) and 
finally observing a drop of coagulating fluid under magnification of a light microscope. Optimum parameters 
determined included concentration of coagulants, temperature and pH. Microscopic viewing included observing after 
centrifugation, under light microscope and SEM. Screening eleven venoms mostly predominantly found in tropical 
region singled out one with the most rapid coagulating timei.e by Calloselasmarhodostoma (CR). Optimization of CR 
venom related to several parameters provided venom concentration, 0.07 (w/v%); pH,7.0; temperature, 45.50C while 
that of rennet were determined to be 0.04±0.02 (w/v%); pH,7.0; temperature, 45.50C, respectively. Under these ideal 
conditions for both coagulants, comparison of their milk coagulation time found CR superior i.e. 0.41±0.02 min 
compared to 4.23±0.05 min for rennet. Milk coagulating assay guided fractionation of CR venom by using HiTrap SP 
FF and consecutively followed by HiPrep 26/60 Sephacryl S200 HR pre-packed columns led to a single band on 
coomassie stained SDS-PAGE gel. Next by LCMS analysis on the SDS PAGE band identified the presence of 
metalloproteinase kistominwithin the venom. EDTA inactivated the venom presumably chelating zinc hence 
suggesting further towards identifying kistomin as the likely protease within this venom with milk-clotting activity. 
Snake venom been potentially identified for yet another application for the benefit of mankind. In this investigation 
Malayan Pit Viper’s protease can play major role in dairy industry if studied further.   
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[I] INTRODUCTION 
The thought of snake venom being only lethal to 
mankind is outdated and no longer a current 
perception for at least those working in the field of 
toxin. Due to many evidences been brought to 
attention showing venom being beneficial for 
mankind strengthened this fact further. Human 
can share benefits from snake venom for it have 
been proven snake venom contributed in many 
field of pharmacology, toxicology and clinical 
field. Researchers had studied the function and 
benefit of the snake venom in pharmacology and 
clinical field especially for its anti-cancer 
properties[1-12], as defibrinating agent [13-14], 
antihypertensive activities [15-16] and related 
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cure for cardiovascular or systemic problems[14, 
17], HIV treatment[18-20], treatment for 
Alzheimer and other degenerative diseases[21], 
anti-microbial[22-27], tools in diagnostics[28-31] 
and so on. 
To highlight just one research area in detail, in 
cancer therapy, Vyas et al.,(2013), isolated active 
constituents of certain snake venom capable to 
bind specifically to tumor cells, thus affects the 
migration and its cell proliferation [2]. It is proven 
that, cytotoxic effects of snake venom show 
potential in fighting against tumor cells. These 
components included cardiotoxin-3 (CTX-3) 
[32]and integrin [33-34]. Cytotoxins found in 
Calloselasmarhodostoma (formerly known as 
Agkristodonrhodostoma) snake venom revealed to 
have anti-cancer property by killing at least half 
percentage of the (CTC50) tumor cells studied 
[35].    
In reality, all these only concluded that venom as a 
mixture no doubt being lethal, however once 
isolated to partial or singular entity been a very 
powerful remedy. Observing and imitating nature 
has been an excellent window into innovations in 
science and technology and here as well that 
conception been well captured to improve on 
another area of life i.e. in food industry. 
Abundance of proteolytic enzymes can induce 
milk coagulation and these proteases results not 
only from its ability to clot the milk but also from 
the relationship between milk clotting ability and 
the general proteolysis which enzyme may 
produce [36]. Proteases from animal, plant and 
microbial sources has been investigated as rennet 
substitute and milk clotting enzymes.  Different 
sources of proteases differ in their physical and 
catalytic properties with some of them have 
capacity to coagulate milk, but most of them are 
not suitable for food industry because of their 
hydrolytic action end in lower yields, fat lost from 
the curd and undesirable changes in texture and 
flavor during cheese aging [37]. Researchers have 
been encouraged to find other sources and 
alternatives of coagulant due to the difficulties in 
finding a suitable coagulant in food industries.  
Milk coagulation can be facilitated by inducing 
micelle aggregation; by enzymatic action (cheese) 
or also by adding acid (form fermented milk) [38]. 
Milk is the emulsion of fat globules and 
suspension of casein micelles in water. Casein 
micelles are hydrophobic with their natural 
tendency to aggregate. Coagulation is achieved by 
adding specific proteolytic enzyme usually rennet 
to the milk when casein micelles stick together 
[39]. κ-casein is a substrate of chymosin is the 
primary agent for milk clotting and proteinases 
which productively coagulate milk could 
recognize sequence from His 98 to Lys111, but 
exhibit specificity for Phe105- Met106 bond of κ-
casein of the casein micelle [40-45]. Hence, 
addition of chymosin (rennet) to milk causes 
coagulation.  
It has been reported that enzyme present in snake 
venom especially those in vipers hydrolyze 
proteins and membrane component which lead to 
blood clotting [46-47]. Nevertheless, no strong 
indications support homology between 
coagulation of blood and milk other than that 
studied long time ago by Jolles&Henschen[48]. 
They compared the clotting of blood and milk and 
found the common features of both process. 
Evidently there are structural homologies between 
κ-casein and N-terminal part of fibrinogen y-
chain. In addition, it has been also suggested 
similarity in cleavage mechanisms between the 
action of thrombin (blood) on fibrinogen and that 
of chymosin (EC 3.4.23.4) on the κ-casein fraction 
of milk. Both of these proteases are known to 
hydrolyze specific linkages resulting in 
development of soluble peptides and insoluble 
polymerized fractions. The specificity found to be 
dependent on amino acid sequence surrounding 
thrombin or chymosin sensitive peptide links (7-9, 
13-16) determine in part of susceptibility of 
thrombin/chymosin hydrolysis [49-50]. Currently, 
unfortunately no other studies found to actually 
correlate these two activities ever since then. 
Nevertheless, these authors’ suggestions of linking 
coagulation of milk to that of blood clothing 
process were more than enough for us to 
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hypothesize and eventually experiment on the 
possibility of snake venom (a highly capable 
blood coagulant) to also coagulate milk. Viper 
venom such as C. rhodostomahas dual effect on 
blood clotting; at particularly low concentration it 
is procoagulant while at higher dosage it acts as 
anticoagulant, the venom is an activator of Factor 
X, which speed up conversion of prothrombin to 
thrombin, results in formation of normal fibrin. 
This clotting activity observed at low 
concentrations estimated due to Factor X activator 
predominant, while at high concentration 
defibrinogenating mechanism is predominant [47]. 
Freitas et al. [51], stated that, the venom has no 
effect on platelet activity at low concentration 
however, at high concentration its effects are 
confounded in by formation of weak fibrin mesh. 
The fibrinogen clotting enzymes found in snake 
venom sample are the most frequent type of blood 
coagulation activator, they are well known among 
members of the family Viperidae (Viperinae and 
Crotalinae). Based on purification efforts, 
Malayan pit viper contains, ancrod which is the 
fibrinogen clotting enzyme responsible to target 
on alpha chain [52-54]. 
 
[II] METHOD 
2.1.Sample collection and preparation                                                                                                                    
A total of ten snake venom samples from various 
species in Malaysia were collected from Perlis 
Snakes Farm, State of Perlis, Malaysia. Venoms 
were milked into sterile universal containers and 
the container stored in an ice-filled insulated box 
to prevent venom deprivation. Samples were kept 
in freezer immediately upon arrival at laboratory 
followed by freeze-drying into powder form. The 
lyophilized powder was then stored at -20   
freezer until further usage. Additionally, 
Najanivea (endemic to Southern Africa) was a 
personal collection of one researcher of this 
study.Rennet from Mucormieheiwas purchased 
from Sigma-Adrich. BD DifcoTM skim milk was 
purchased from Thermo Fisher Scientific, USA.  
2.2. Determining Protein Content 
Protein content in samples were determined by 
following the modified procedures of Bradford 
[55],with an initial stock of 2 mg/ml of bovine 
serum albumin (BSA) purchased from Thermo 
Scientific, USA to be used to derive the standard 
curve.  
2.3. Determining Coagulation Time of Various 
Snake Venom Samples 
A total of 0.04% (w/v) of venom was weighed and 
dissolved in 1.5 ml of 5% (w/v) freshly prepared 
skim milk with temperature and pH maintained 
constant at 250C and pH 7.0, respectively. The 
amount of CaCl2 was provided in excess at 
concentration of 0.8% (w/v). Immediately after 
the venom was added into milk solution, the end 
point of coagulation was determined by observing 
for visible clot formation as described by Farah & 
Bachmann [56], (with few modifications). Briefly, 
this was done using three visible parameters i.e. 
change in viscosity, colour changes and white spot 
formation (separation between curd and whey). 
Consequently, upon observing this changes a final 
confirmation of coagulation done by observing a 
drop of the fluid under magnification of a light 
microscope. The coagulation time was defined as 
the time required for the first appearance of 
graininess in the moving film of milk on the
surface of the glass wall [56].  
2.4.Determining Optimum Parameters of C. 
rhodostoma and M. meihei rennet 
The parameters determined were optimum protein 
concentration of samples, temperature and pH. In 
determining the optimum protein concentration, 
serial dilution of CR venom andM. meiheirennet 
were prepared ranging from 0.0045 % - 0.2845 % 
(w/v) of different protein concentration of rennet 
and snake venom in 1.5 mL of skim milk sample 
with other parameters maintained constant at 250C 
temperature and pH 7.0. The time taken for 
coagulation was recorded. 
Next, the protein concentration of 0.07% (w/v) of 
CR venomand 0.04% (w/v) M. meiheirennet were 
used for the determination of the optimum 
temperature andpH.For the latter, 0.1M Potassium 
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Phosphate buffer was prepared ranging from pH 
6.0 to 8.0, while incubation in water bath at 
temperature ranges between 30  to 60  used for 
the other parameters. Each of the coagulant 
samples was dissolved in 1.5 mL of skim 
milkcontaining CaCl2 of 0.8% (w/v). The 
parameters of temperature and pH maintained to 
be constant (except for the investigated parameter) 
at 250C and pH 7.0. Time taken to record 
coagulation time is as described earlier.  
2.5. Microscopy Techniques 
 
2.5.1. Optical Microscope 
An observation was carried out by observing a 
drop of milk (uncoagulated and undergoing 
coagulation) in a light microscope (Nikon Eclipse 
E100, USA) fitted with digital imager (DinoEye 
Eyepiece Camera Software).   
2.5.2. Scanning Electron Microscope (SEM)  
The freeze-dried specimens (curd formed due to 
CR and rennet, and milk alone) were sent for SEM 
(Fei Quanta 450, Thermo Fisher Scientific, USA) 
analysis at Central Laboratory, Universiti 
Malaysia Pahang, Malaysia. 
 
2.6. Milk Coagulation Guided Isolation and 
Identification of Active Protein 
 
2.6.1.Ion Exchange Chromatography  
The HiTrap SP FF (GE Healthcare Life Sciences) 
pre-packed with SulfopropylSepharose Fast Flow, 
a strong cation connected to the ÄKTAexplorer 
(Amersham Biosciences, Sweden). A 50mM 
ammonium acetate at pH 6.0 and 1.0M NaCl in 
50mM ammonium acetate at pH 6.0 were the start 
buffer and elution buffer (Buffer B). The 
parameters programmed to a method template as 
follows: 
Flow rate: 1.0 mL/min; Fraction size: 4.0 mL; 
Sample injection: 0.5 mL; Equilibration volume: 
15 mL; Wash out unbound: 10 mL; Elution 
volume: 30 mL; Re-equilibration volume: 15 mL 
and the linear gradient elution as shown in Fig 1. 
 
Fig: 1.Concentration of Buffer B (%) versus Eluent 
Volume (mL). 
 
The fractions were collected, freeze dried and 
consequently desalted using HiTrap Desalting 
(GE Healthcare Life Sciences, USA), a pre-
packed Sephadex G-25 Superfine column. The 
column was connected to the ÄKTAexplorer 
(Amersham Biosciences, Sweden) and utilized a 
standard template program for desalting contained 
within it. 
2.6.2. Size Exclusion Chromatography 
The active fraction eluted from ion exchange 
chromatography column (HiTrap SP FF) was 
applied onto HiPrep 26/60 Sephacryl S 200 HR 
pre-packed column (GE Healthcare Life Sciences, 
USA). The column was connected to the 
ÄKTAexplorer (Amersham Biosciences, 
Sweden). The column was equilibrated with 
50mM of ammonium acetate buffer of pH 7 and 
the elution was carried out using the same buffer 
with 2 ml sample injection at flow rate of 
1ml/min. The fractions of 6 ml were collected and 
the peak was monitored by recording the 
absorbance at 280nm. 
2.6.3. SDS PAGE  
SDS PAGE was performed to determine the purity 
of fractions with positive results. A 12% 
separating gel and 5% stacking gel were prepared 
and ran on 150 Volts until the dye reached the 
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bottom of the gel. The gel was then stained with 
warm Coomassie blue staining solution 
(PhastGelTM Blue R, GE Healthcare Life Sciences, 
USA) to allow the visualization of bands. The 
staining solution was discarded and de-stained 
with intermittent changes of 10% acetic acid 
solution until a clear visualization of bands on a 
shaker.    
2.6.4. Mass Spectrometry Analysis 
The protein band was excised from the SDSPAGE 
gel and placed in a microcentrifuge tube. The 
sample sent for identification using Liquid 
Chromatography Tandem Mass Spectrometry 
(LC-MS/MS) by Proteomics International, 
Australia. Briefly, protein sample was trypsin 
digested and peptides extracted. Peptides were 
analysed by electrospray ionisation mass 
spectrometry using the Shimadzu Prominence 
nano HPLC system (Shimadzu, Japan) coupled to 
a 5600 TripleTOF mass spectrometer [Sciex]. 
Tryptic peptides were loaded onto an Agilent 
Zorbax 300SB-C18, 3.5 µm (Agilent 
Technologies, USA) and separated with a linear 
gradient of water/acetonitrile/0.1% formic acid 
(v/v). 
 
[III] RESULTS 
Table 1. Milk coagulation time of various snake 
venoms. 
 
Sample Protein 
content 
(µg) 
Mean ± 
SE 
Percenta
ge of 
protein 
(%) 
Coagulati
on time 
(minutes) 
mean ± 
SE 
Calloselasmarhodostoma 
(viper) 
778.89±0.
03 
77.8 2.83±0.10 
Najasputatrix 
(cobra) 
268.40±0.
01 
26.8 3.33±0.34 
Trimeresuruswagleri(viper
) 
574.36±0.
01 
57.4 3.67±0.56 
Bungaruscandidus 
(krait) 
478.63±0.
02 
47.9 12.00±0.5
1 
Najakaouthia 
(cobra) 
384.91±0.
00 
38.5 15.03±0.1
9 
Ophiophagushannah(cobra
) 
287.18±0.
02 
28.7 30.00±0.1
9 
Najanivea 
(cobra) 
752.14±0.
02 
75.2 47.00±0.4
7 
Bungarusfasciatus 
(krait) 
678.63±0.
01 
67.9 ˃ 60* 
Trimeresurushageni(viper) 628.59±0.
01 
62.9 ˃ 60* 
Trimeresurussumatranus(v
iper) 
428.21±0.
00 
42.8 ˃ 60* 
Trimeresuruspurpureomac
-ulatus 
 (viper) 
547.01±0.
02 
54.7 ˃ 60* 
 
Data presented as standard error (SE) with repeats of 
n=3. The end point was recorded when discrete 
particles (whitish liquid) were discernible. *denotes 
those samples unable to show convincing coagulation 
immediately.  
 
3.1. Coagulation Time of Various Snake Venom 
Samples  
The milk coagulation time for various snake 
venoms are as shown in Table 1. CR found with 
the most rapid coagulating activity of 2.83±0.10 
minutes (also incidentally with the highest protein 
content of 77.8%), and Najasputatrix(26.8% 
protein content) andTrimeresuruswagleri(57.4% 
protein content) followed next with coagulating 
time to be less than four minutes. Hence, no direct 
correlations can be made between coagulation 
time and protein content.  
 
3.2. Optimum Parameters of CR and rennet 
In determining the optimum coagulating 
parameters for CR and rennet, an initial 
investigation to find out the optimum amount 
required for the coagulating activity was carried 
out.  As shown in Fig 2 (graph A & B) the amount 
of 0.07% and 0.04% (w/v) of CR and rennet 
respectively determined as the optimum protein 
content required for each of the coagulant.  
These amounts were next utilized in the 
determination of other parameters and results been 
summarized in  
Table 2. The optimum values for each parameter 
(pH and temperature) were obtained based on 
graphs (C to F) shown in Fig 2.  
The graphs of A-B provided similar patterns for 
the rate of coagulation whereby observed to be 
reaching a plateauing effect. While the graphs of 
C-F, a pattern of non-symmetrical bell shape with 
an obvious peak.   
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Fig: 2. Determining optimum parameters byA: 
increasing CR protein concentration (w/v%); B: 
increasing rennet protein concentration (w/v%); 
C: varying pH environment for CR; D: varying pH 
environment for rennet;  E: varying temperature 
for CR; F: varying temperature for rennet. 
 
As shown in Table 2, the optimum pH and 
temperature determined for both rennet and 
CRwere pH 7.0 and 45.4oC, respectively. Though 
both coagulants had similar optimum conditions 
(i.e. pH 7.0 and temperature of 45.5oC), the 
coagulation time differed markedly as CR was 
found better in its coagulating rate once tested 
with their optimum conditions as shown in Table 
2.  
Table 2.Summary of optimum conditions for C. 
rhodostoma venom and rennet. 
Parameter 
CR Rennet 
Optimu
m 
condition 
Coagulatio
n time 
(minute) 
Optimu
m 
condition 
Coagulatio
n time 
(minute) 
Protein 
concentratio
n (w/v%) 
0.07  1.36±0.01 0.04 23.00±0.58 
pH 7.0 2.50±0.03 7.0 6.20±0.12 
 
Temperature 45.5
 o C 0.34±0.03 45.5 o C 2.00±0.25 
#Comparison 
of CR and 
rennet 
0.07; 7.0; 
45.5oC 0.41±0.02 
0.04; 7.0; 
45.5oC 4.23±0.05 
#The coagulation time of CR venom and rennet 
under their respective optimum conditions.  
All data presented as ±SE with repeats of n= 3. 
 
 
3.3. Microscopic View of Samples   
The visuals (Fig 3) of pre- and post-coagulations 
showed (X-Z) images of milk before and after 
coagulation by CR and rennet viewed in three 
different observations i.e. after centrifugation, 
under light microscope and SEM. Evidently, milk 
appeared soluble throughout even after 
centrifugation while in both CR and rennet treated 
milk a clear curd (precipitated at the bottom) and 
whey (solution) being separated signifying 
coagulation.  
The curds formed (moldy looking) due to these 
two coagulants were easily differentiated from 
milk under a low magnification using a light 
microscope.    
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Fig: 3.pre- and post-coagulations of milk:Inset of X 
boxed area showing a tube containing 1 ml of 
uncoagulated milk (control), structure of milk at 
low magnification (100X) viewed with light 
microscopy (center) and SEM image of freeze 
dried milk  (far right) at 3.50KX. Inset of Y boxed 
area showing a tube of milk with clear visible 
separation of curd and whey after coagulation by 
CR and centrifuged at 10,000 rpm for 2 minutes, 
structure of CR coagulated milk at low 
magnification (100X) viewed with light 
microscopy (center) and SEM image of freeze 
dried curd (far right) at 3.50KX. Inset of Z boxed 
area showing a tube of milk with clear visible 
separation of curd and whey after coagulation by 
rennet and centrifuged at 10,000 rpm for 2 
minutes, structure of rennet coagulated milk at 
low magnification (100X) viewed with light 
microscopy (center) and SEM image of freeze 
dried curd (far right) at 3.50KX.  
The images of freeze-dried milk, viewed under 
SEM showed individual structures of casein 
micelles. It has round, spherical like shape and 
distributed evenly throughout the milk sample.  
The image of caseinate curd due to CR showed 
strong shadowing effects due to surface roughness 
by the development of strands of gel formed due 
to coagulation. The particles surface showed 
clump of uneven surface forming compact 
structure. Caseinate curd of rennet showed 
uneven, irregular clumps with much larger hollow 
space which appeared as if to be large globular 
particles emerging from their interior and forming 
a thread of network. 
 
3.4. Identification of the Coagulant within C. 
rhodostoma 
As shown in Fig 4(a), a total of 4 peaks were 
eluted out and the desalting done for all cumulated 
fractions. Upon screening the freeze dried 
fractions for coagulating activity only peak 2a 
observed with activity. Consequent, stepwise size 
exclusion chromatography of protein mixture 
within the relevant peak 2a provided profile as 
shown in Fig 4(b) with significant coagulation to 
be present in peak 5b only. The coagulation 
activity is as shown in Fig. 5. 
 
Fig: 4.Chromatograms of protein separations.(a) 
HiTrap SP FF cation exchange chromatography of 
10mg CR crude venom and (b) Size exclusion of active 
peak 2a (25mg) separated into peaks of 1b - 6b. 
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Fig: 5.Coagulation by fraction in peak 5b.Inset of 
boxed area showing a tube of milk with clear visible 
separation of curd and whey after coagulation by 
fraction in peak 5b once centrifuged at 10,000 rpm for 
2 minutes and structure of coagulated milk at low 
magnification (100X) viewed with light microscopy 
(center). On the far right, SDS-PAGE gel; Lane 1: Low 
Molecular Weight Calibration Kit (GE Healthcare 
Biosciences, USA) molecular marker, Lane 2: Crude 
venom of CR, Lane 3: HiPrep 26/60 Sephacryl S 200 
HR size exclusion chromatography obtained peak 5b. 
 
Table 3. Protein Identification Summary on the SDS 
PAGE Gel Band of Peak 5b. 
Search Parameters Results 
Database/version: 
MSPnr100/Mascot 
2.4.1 
protein hit and rank: 1 
Variable 
modification: 
oxidation (M) 
protein accession: P0CB14 
Taxonomy filter: 
Serpentes (June 2017; 
121,572 sequences) 
Protein description: 
sp|P0CB14|VM1K_CALRH 
Snake venom metalloproteinase 
kistomin n=1 Tax_Id=8717 
[Calloselasmarhodostoma] 
Enzyme: Trypsin Protein score: 658 
Maximum Missed 
Cleavages: 1 emPAI: 1.49 
Peptide & fragment 
mass tolerances: 
±0.2Da 
peptides matched: 30 (18 non-
duplicate, 12 duplicate) 
Mass values: 
Monoisotopic 
Peptides (non-duplicate only): 
107, 140, 142, 153, 211, 575, 576, 
702, 705, 796, 889, 917, 918, 945, 
950, 997, 1094, 1120 
Instrument type: 5600 
TripleTOF mass 
spectrometer [AB 
Sciex], ESI-QUAD-
TOF 
Peptides found significant and top 
ranking: 9 
Data in Table 3 indicated the protein hit ranked 
number one due to the highest score attained. The 
protein identified as snake venom 
metalloproteinase (SVMP) kistomin belonging to 
the snake of Calloselasmarhodostoma. Evidently, 
no other protein belonging to the database of CR 
identified within the hit list.Hence, the kistomin 
enzyme was purified from C. rhodostomaas 
asingle band with molecular weight found 
between 20-30kDa on SDS-PAGE (Fig 
5).Similarly, Vejayan et al. [57], in their attempt 
to map the proteome of Calloselasmarhodostoma 
identified kistomin as an intense two dimensional 
electrophoresis (2-DE) spot between molecular 
weight of 20-30kDa.  
Table 4. Coagulation activity in presence of a chelating 
agent. 
Samples 0.07% 
(w/v) 
CR 
only 
0.07% 
(w/v) CR 
in 50mM 
EDTA 
Kistomin 
only 
Kistomin 
in 50mM 
EDTA 
Coagulation 
of 5 % (w/v) 
milk 
+ -- + -- 
+, coagulated within a minute; --, no coagulation 
 
Table 4 showed results of0.03% (w/v) 
kistomintreated to milk in the absence and the 
presence of 50mM ethylenediaminetetraacetic 
acid (EDTA). Only milk treated with CR and 
kistominprovided a tube with clear separation 
between whey and curd after centrifugation at 
10,000 rpm for 2 minutes (figure not provided). 
Kistomin been reported to be deactivated in the 
presence of EDTA (a chelating agent). Evidently 
in this experiment no coagulation observed once 
the EDTA been included in tubes containing 
either CR or the isolated kistomin alone.Hence, 
indicating kistominto be the protease acting as the 
coagulant within the CR venom.   
 
[IV] DISCUSSION 
Generally, venoms of Viperidae known to contain 
more haemotoxin and metalloproteinase exerting 
strong proteolytic activity while Elapid venoms 
contain neurotoxins and cardiotoxin hence with 
weaker proteolytic activity [58-59]. The 
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comparison of proteome in four snake venoms 
belonging to Viperidae and Elapidae by Vejayan 
et al. [57], showed clear distinction with Viperidae 
venoms prominent with more of higher molecular 
weight spots in 2-DE compared to the Elapidae 
venoms studied with mostly lower molecular 
weight 2-DE spots (presumably belonging to 
neurotoxins). Apart from the two viper species i.e. 
CalloselasmarhodostomaandTrimeresuruswagleri
shown with rapid milk coagulations while the 
other three vipers Trimeresurushageni, 
Trimeresurussumatranus and 
Trimeresuruspurpureomaculatusprovided 
unconvincing activity of more than an hour. 
Similarly, no direct correlation can be made 
between protein content of venom and coagulating 
activity. In this study, the protein content of the 
eleven snake venoms was between 30 and 80%. 
Generally, snake venoms mainly comprise of 
protein which make 70-90% of the dry weight of 
snake venom [2, 60]. Different species have 
different types of venoms and even the 
composition of protein within the single species 
vary depending on age, climate, geographical 
location, its habitat, diet and etc[61-63].Mackessy 
et al. [64] has conducted a study of protein content 
in four growth categories (neonates, juveniles, 
adults and large adults) of Boigairregularissnake 
and found that the percentage of the protein 
content in this snake is increasing from 47.5 to 
90.2% as the snake aged.  
Interestingly, Najasputatrix(spitting cobra) venom 
found with high milk coagulating activity even 
though with the lowest protein content. 
Najasputatrix (also known as Javan spitting cobra) 
venom may have evolved from a specialization of 
prey ingestion rather than prey capture, since the 
venom can cause disruption of the cornea and 
produces intense pains when in contacts with eye 
[65].Moreover, it has been found that, 5% of N. 
sputatrix venom dry weight consists of high 
molecular weight proteins and enzymes (> 30000 
MW); and the enzymes composition include 
phosphodiesterase, 5'-nucleotidase, protease, L-
amino acid oxidase, hyaluronidase, alkaline 
phosphomonoesterase and acetylcholinesterase 
[66-67]. 
Meanwhile, elapid snake (with the exception of 
Najasputatrix) from this study also possess 
coagulation activity but the time taken for 
coagulation is much longer than viper species. 
Elapid species mainly comprised of neurotoxins 
[57] and have weak proteolytic activity [58]. In 
addition, elapid venoms contain various active 
basic polypeptides (non-enzymatic) which 
constitute 25-60% of the venom dry weight and 
have fewer enzymes than viper venoms [66]. 
Najakaouthia venom consists of enzymes mostly 
being high molecular and composition differing 
from Najasputatrix venom. The former has higher 
neurotoxin content than Najasputatrix[66]. In this 
study, Ophiophagushannahvenom also exhibited 
milk coagulation activity. Ophiophagushannahor 
also known as King Cobra has relatively higher 
enzyme content than venoms of most cobras. The 
biological active elements that have been 
characterized are neurotoxin, hemorrhagic and 
non-hemorrhagic proteases, L-amino acid oxidase, 
phospholipase A2 enzymes and alkaline 
phosphomonoesterases[66]. This venom contains 
five proteases which is likely hemorrhagic 
protease types having molecular weight around 
70000daltons[68]. Furthermore, the previous 
study by Vejayan et al. [57], found the protein 
map of Ophiophagushannah displayed 
dissimilarities in relation to the other two elapids 
(Najakaouthia and Bungarusfasciatus). In the 2-
DE proteome profile of the venoms, protein spots 
of Ophiophagushannah venom were displayed at 
the higher molecular mass region similar to the C. 
rhodostoma. 
In this study, C. rhodostomavenom sample 
exhibited excellent milk clotting activity and was 
selected for optimization of parameters together 
with commercialized Mucormieheirennet. Apart 
from the protein concentration, all other 
parameters i.e. pH and temperature were found 
similar as optimum conditions of both samples. 
Calcium chloride was added in excess to the skim 
milk as a firming agent. Zerrin[69] claimed 
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accumulation of calcium escalates rate of firming 
of rennet-induced milk gel (curd) and firmness of 
gel (curd). Calcium chloride causes charge 
neutralization of negatively charged groups found 
on casein micelle surface and possible 
development of calcium bridges which speed up 
the clotting as well. Interestingly, distinctive bell 
shaped curves with maximum peaks denoting 
optimum pH and temperature commonly obtained 
for any enzyme. Upon performing coagulating 
activity using these ideal conditions for each 
sample, it was determined C. rhodostomavenom 
was superior to rennet. The rennet used is a 
recombinant fungal, Mucormiehei,derived source. 
It comprises of proteins with higher level of purity 
compared to the crude venomincidentally explains 
the use of almost double the amount of C. 
rhodostomavenom for the optimum coagulating 
activity.  
Three visual observations clearly separated the 
coagulated (by CR and rennet) and uncoagulated 
outcomes of milk. Such indicators relevant as the 
evaluation method for coagulation required to be 
customized for this study due to the low amount 
of venom material available from the snakes. 
Though a number of milk coagulation method 
available none found suitable to be used in 
evaluating the milk coagulating activity of snake 
venoms such as ultrasonic[70-72], heated 
thermistor [73], formagraph [74-75], rheological 
assay [76-77], NIR light backscatter [77-78],mid-
Infrared reflectance spectroscopy [79] and diffuse 
reflectance [80].Based on the SEM images of 
freeze dried milk sample, the micelles are 
markedly found to be separated from each other 
and found to contain in groups. According to 
Mimouni et al. [81], the surface of the particles 
was principally smooth; any roughness on its 
surface is due to the consequence of freeze-dried 
technique done.  
Isolation of the coagulant present within CR 
involvedstep wise assay guided purification by 
initial ion exchange separation followed by size 
exclusion chromatography and consequent gel 
band de novo peptide mass spectrometry analysis 
to finally identifySVMP kistomin as the highest 
scored match. The approach involved mass 
spectra data of the unknown peptide within 
protein in peak 5b submitted and found the most 
appropriate match with known peptide sequence 
of CR protein database. The results of the protein 
identified was in contrast to the earlier expected 
protease i.e. ancrod, being the major form of 
thrombin like-enzymes in C. rhodostoma venom.  
Ancrod is a reptilian fibrinogenases with a high 
degree of sequence similarity to those of 
mammalian serine proteinase [66, 82]. While 
SMVP kistomin is also a fibrinogenase capable of 
cleaving (protease activity) specifically the 
glycoprotein platelets to impair their function to 
cause hemostasis. This zinc containing enzyme (as 
such known to be inhibited by EDTA chelating 
agent) having 25kDa molecular weight belongs to 
the C. rhodostoma venom metaloproteinase 
(M12B) family capable to selectively cleave 
human platelet glycoprotein Ib[83-85]. Hence, the 
function of SMVP kistomin in coagulating milk 
can be explained due to its protease activity. In 
general, as it is similar to chymosin function, 
likely SMVP kistomin too specifically cleaves κ-
casein fraction of milk resulting in development of 
insoluble fractions which polymerizes[86-87]. The 
recent studies had found that metalloproteinases 
isolated from Paenibacillusspp. [88-89]and 
Termitomycesclypeatus[90] have the ability to 
induce milk clotting. The specificity of the 
coagulant in cleaving casein within its amino acid 
sequence is crucial as other viper venom studied 
(expected to contain protease as well) unable to 
coagulate milk as comparable to C. rhodostoma.  
 
[V] CONCLUSION 
This study identified the potentials of snake 
venom in coagulating milk as whole and more 
importantly the ability of one outstanding venom 
related to this activity. A comparison with 
commercial milk coagulant indicated potentials of 
the Malayan Pit Viper venom and consequently 
identified the protease within this venom to be 
metalloproteinase of kistomin. Though yet again 
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doubts may arise in considering venom protease 
as a likely coagulant for the dairy industry due to 
its low abundance from snake however it is 
expected with the eventual genetic engineering of 
it’s gene into a suitable microbe may overcome 
this challenge.This work merely proposes a 
protease originating from snake venom uniquely 
capable to coagulate milk. Whether it is able to be 
utilized commercially is another challenge 
altogether. 
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